BLOOMFIELD, Conn., Jan. 12, 2023 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) will release its fourth quarter 2022 financial results on Friday, February 3, 2023, and will host a conference call the same day.
Fourth quarter 2022 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:
Live Call
(888) 455-5036 (Domestic)
(773) 799-3981 (International)
Passcode: 2032023
Replay
(800) 839-2290 (Domestic)
(203) 369-3607 (International)
It is strongly suggested that participants dial in to the conference call by 8:15 a.m. ET on February 3. A replay of the call will be available from 12:30 p.m. ET on February 3 until 11:59 p.m. ET on February 17, 2023. Additionally, the conference call will be available on a live internet webcast at https://investors.cigna.com/events-and-presentations/default.aspx in the Investor Relations section of Cigna's website. Please note that this feature will be in listen-only mode.
A copy of the company's news release and financial supplement will be available on Cigna's website in the Investor Relations section at https://investors.cigna.com/home/default.aspx, no later than 6:30 a.m. ET on February 3.
About Cigna
Cigna Corporation is a global health services company dedicated to improving the health, well-being and peace of mind of those we serve. Cigna delivers choice, predictability, affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products. Cigna maintains sales capability in over 30 countries and jurisdictions, and has over 190 million customer relationships around the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.
Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Contact
Justine Sessions
1 (860) 810-6523
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$337.63 |
Daily Change: | 1.12 0.33 |
Daily Volume: | 17,551 |
Market Cap: | US$93.910B |
October 31, 2024 September 12, 2024 September 12, 2024 August 01, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB